Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Hypotension 1Head and Neck Neoplasms 1Goiter 1Anus Neoplasms 1

Interventions

Cetuximab 4pembrolizumab 3Trastuzumab 3Radiotherapy 3Erlotinib Hydrochloride 3Tomography, X-Ray Computed 2Magnetic Resonance Spectroscopy 2Fluorodeoxyglucose F18 2Docetaxel 2Biopsy 2ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1tipifarnib 1sargramostim 1sapanisertib 1relatlimab 1pertuzumab 1palbociclib 1osimertinib 1omipalisib 1oblimersen 1nanocis 1mercaptoundecahydrododecaborate 1larotrectinib 1ipatasertib 1fluoromisonidazole 1erythromycin propionate-N-acetylcysteinate 1erdafitinib 1entinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rectal Neoplasms × Epinephrine × Head & Neck × Clear all
NCT04432597 2026-05-18

HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Active not recruiting
39 enrolled
GastrointestinalGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡